SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-22-039152
Filing Date
2022-10-31
Accepted
2022-10-31 17:06:51
Documents
17

Document Format Files

Seq Description Document Type Size
1 DEFM14A ny20005658x1_defm14a.htm DEFM14A 5668342
2 logo_renovacor.jpg GRAPHIC 34389
3 logo_renovacorx1.jpg GRAPHIC 43626
4 logo_rocketpharma.jpg GRAPHIC 29648
5 logo_rocketpharmax1.jpg GRAPHIC 36798
6 logo_svbsecurities.jpg GRAPHIC 33212
7 ny20005658x1_annbfoot.jpg GRAPHIC 55062
8 ny20005658x1_graphic01.jpg GRAPHIC 241231
9 ny20005658x1_graphic02.jpg GRAPHIC 81990
10 ny20005658x1_graphic03.jpg GRAPHIC 123121
11 ny20005658x1_graphic04.jpg GRAPHIC 102297
12 ny20005658x1_graphic05.jpg GRAPHIC 124975
13 ny20005658x1_graphic06.jpg GRAPHIC 127793
14 ny20005658x1_graphic07.jpg GRAPHIC 65647
15 ny20005658x1_pc01.jpg GRAPHIC 586742
16 ny20005658x1_pc02.jpg GRAPHIC 570605
17 sig_magdalenecook.jpg GRAPHIC 11680
  Complete submission text file 0001140361-22-039152.txt   8791341
Mailing Address 201 BROADWAY SUITE 310 CAMBRIDGE MA 02139
Business Address 201 BROADWAY SUITE 310 CAMBRIDGE MA 02139 610-424-2650
Renovacor, Inc. (Filer) CIK: 0001799850 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39271 | Film No.: 221346975
SIC: 2836 Biological Products, (No Diagnostic Substances)